Stephens Forecasts Strong Price Appreciation for PACS Group (NYSE:PACS) Stock

PACS Group (NYSE:PACS) had its target price boosted by equities research analysts at Stephens from $60.00 to $64.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Stephens‘s price objective would suggest a potential upside of 28.82% from the company’s current price.

Several other research analysts have also recently weighed in on the stock. Oppenheimer upped their price target on shares of PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Royal Bank Of Canada lifted their price objective on PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research note on Thursday, August 6th. JPMorgan Chase & Co. boosted their target price on PACS Group from $47.00 to $58.00 and gave the stock an “overweight” rating in a research report on Friday, September 4th. Zacks Research lowered PACS Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 9th. Finally, Truist Financial set a $62.00 price target on PACS Group in a report on Wednesday, September 2nd. Seven research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, PACS Group currently has an average rating of “Moderate Buy” and an average target price of $61.33.

PACS Group Price Performance

Shares of PACS Group stock traded down $0.52 on Thursday, reaching $49.68. The stock had a trading volume of 874,681 shares, compared to its average volume of 816,441. The business’s 50 day moving average is $44.64 and its two-hundred day moving average is $40.03. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21. PACS Group has a 1 year low of $10.31 and a 1 year high of $51.68. The company has a market cap of $7.86 billion, a P/E ratio of 28.07, a price-to-earnings-growth ratio of 1.42 and a beta of -0.14.

PACS Group (NYSE:PACS) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.58 by $0.05. The company had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.46 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. As a group, research analysts anticipate that PACS Group will post 2.13 EPS for the current year.

Insider Buying and Selling at PACS Group

In related news, Director Mark Hancock sold 186,696 shares of the stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $50.45, for a total value of $9,418,813.20. Following the transaction, the director owned 53,318,884 shares of the company’s stock, valued at $2,689,937,697.80. This represents a 0.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jason Murray sold 167,434 shares of the stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $50.24, for a total value of $8,411,884.16. Following the completion of the transaction, the chief executive officer directly owned 53,954,101 shares in the company, valued at approximately $2,710,654,034.24. This represents a 0.31% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,762,431 shares of company stock valued at $80,686,053 over the last quarter. 70.10% of the stock is owned by company insiders.

Hedge Funds Weigh In On PACS Group

A number of large investors have recently modified their holdings of the company. Nisa Investment Advisors LLC lifted its position in PACS Group by 11.0% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,327 shares of the company’s stock worth $97,000 after buying an additional 230 shares during the last quarter. Financial Management Professionals Inc. grew its position in PACS Group by 54.9% during the second quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock valued at $28,000 after acquiring an additional 235 shares during the last quarter. Smith Group Asset Management LLC raised its stake in shares of PACS Group by 1.3% during the third quarter. Smith Group Asset Management LLC now owns 24,680 shares of the company’s stock worth $1,025,000 after acquiring an additional 320 shares in the last quarter. Jacobsen Capital Management lifted its holdings in shares of PACS Group by 3.4% in the 3rd quarter. Jacobsen Capital Management now owns 17,837 shares of the company’s stock worth $741,000 after acquiring an additional 579 shares during the last quarter. Finally, Toth Financial Advisory Corp lifted its holdings in shares of PACS Group by 87.5% in the 3rd quarter. Toth Financial Advisory Corp now owns 1,500 shares of the company’s stock worth $62,000 after acquiring an additional 700 shares during the last quarter.

Key PACS Group News

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: Quarterly results beat expectations and outlook rose. PACS reported Q3 EPS of $0.63 and revenue of $1.50 billion, topping estimates; adjusted EBITDA increased 33.6%. Management raised its 2026 revenue forecast to $5.95–$6.05 billion and adjusted EBITDA outlook to $685–$695 million. Q3 earnings coverage Raised 2026 outlook
• Positive Sentiment: Expansion and facility ramp-ups may support continued growth. Recent acquisitions in Florida and Texas, along with the Eduro deal, add about 8,400 beds. Company leaders cited occupancy near 90%, while newer facilities mature and move toward higher occupancy and patient acuity. Acquisitions and results Occupancy and acquisitions
• Positive Sentiment: Analysts raised targets and maintained bullish ratings. Truist lifted its target to $65 and kept Buy; Stephens raised its target to $64 with an Overweight rating. UBS also raised its target to $67 and maintained Buy. Truist target update Stephens forecast
• Negative Sentiment: Executives and a director disclosed stock sales. CEO Jason Murray and director Mark Hancock sold shares, as did the CAO. The transactions were made under pre-arranged Rule 10b5-1 plans, and the CEO and director retained substantial holdings, which may temper concerns. Director sale CEO sale

About PACS Group

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.